A Plan to Fix the Dreaded SGR Formula? The sustainable growth rate formula first came on the scene during the Clinton administration, but has since derailed. Is there a way to right the wrongs?
A False Start on Biosimilar Savings? As the FDA continues to work on the biosimilars approval process, there are growing concerns that a true cost-savings can't be realized.